The E.I.E.V. Arydani, the largest and most advanced starship ever constructed by human hands, launched from the planet Themis to embark on a great mission of interstellar exploration called The Grand Tour. The Arydani was lost with all hands during her maiden voyage...vanished without a trace. That was over three hundred years ago. Since that time, the Arydani has appeared and reappeared randomly throughout the Alliance territories like a ghost ship...an interstellar Flying Dutchman. Now, on a routine run, the crew of the deep space cargo/salvage starship Brysen makes a discovery that could very well solve the mystery of the Arydani once and for all...or the three-century-old derelict of the spacelanes and the dreadful secrets it contains will claim yet another collection of victims.

Title: A Guide to Modern English History. 1815-1830(-1835) pt. 1, 2.Publisher: British Library, Historical Print EditionsThe British Library is the national library of the United Kingdom. It is one of the world's largest research libraries holding over 150 million items in all known languages and formats: books, journals, newspapers, sound recordings, patents, maps, stamps, prints and much more. Its collections include around 14 million books, along with substantial additional collections of manuscripts and historical items dating back as far as 300 BC.The HISTORY OF BRITAIN & IRELAND collection includes books from the British Library digitised by Microsoft. As well as historical works, this collection includes geographies, travelogues, and titles covering periods of competition and cooperation among the people of Great Britain and Ireland. Works also explore the countries' relations with France, Germany, the Low Countries, Denmark, and Scandinavia. ++++The below data was compiled from various identification fields in the bibliographic record of this title. This data is provided as an additional tool in helping to insure edition identification: ++++ British Library Johnson, Cory William; 1880, 82. 8 . 9525.d.10.

Title: A Guide to Modern English History. 1815-1830(-1835) pt. 1, 2.Publisher: British Library, Historical Print EditionsThe British Library is the national library of the United Kingdom. It is one of the world's largest research libraries holding over 150 million items in all known languages and formats: books, journals, newspapers, sound recordings, patents, maps, stamps, prints and much more. Its collections include around 14 million books, along with substantial additional collections of manuscripts and historical items dating back as far as 300 BC.The HISTORY OF BRITAIN & IRELAND collection includes books from the British Library digitised by Microsoft. As well as historical works, this collection includes geographies, travelogues, and titles covering periods of competition and cooperation among the people of Great Britain and Ireland. Works also explore the countries' relations with France, Germany, the Low Countries, Denmark, and Scandinavia. ++++The below data was compiled from various identification fields in the bibliographic record of this title. This data is provided as an additional tool in helping to insure edition identification: ++++ British Library Johnson, Cory William; 1880, 82. 8 . 9525.d.10.

Hren-Tikaar, a notorious former assassin, carries within him enough information to topple a major galactic underworld syndicate. Ranger special agent Galan Rojai must transport him to a special inquest on the Alliance capitol of Themis. Attacks from without and within, and a chance encounter with a freak wormhole leave these two men stranded on a planet in the middle of nowhere. Now, in a hostile environment and with enemies on the prowl, two men from opposite sides of the law are going to find that trust is their only way out.

Orphan drugs are designated drug substances that are intended to treat rare or 'orphan' diseases. More than 7000 rare diseases are known that collectively affect some 6-7% of the developed world's population; however, individually, any single, rare disease may only affect a handful of people making them commercially unattractive for the biopharmaceutical industry to target. Ground breaking legislation, starting with the Orphan Drug Act that was passed in the US in 1983 to provide financial incentives for companies to develop orphan drugs, has sparked ever increasing interest from biopharmaceutical companies to tackle rare diseases. These developments have made rare diseases, and the orphan drugs that treat them, sufficiently attractive to pharmaceutical development and many pharmaceutical companies now have research units dedicated to this area of research. It is therefore timely to review the area of orphan drugs and some of the basic science, drug discovery and regulatory factors that underpin this important, and growing, area of biomedical research. Written by a combination of academic and industry experts working in the field, this text brings together expert authors in the regulatory, drug development, genetics, biochemistry, patient advocacy group, medicinal chemistry and commercial domains to create a unique and timely reference for all biomedical researchers interested in finding out more about orphan drugs and the rare diseases they treat. Providing an up-to-date monograph, this book covers the basic science, drug discovery and regulatory elements behind orphan drugs and will appeal to medicinal and pharmaceutical chemists, biochemists and anyone working within the fields of rare disease research and drug development or pharmaceuticals in industry or academia.